Aegis Capital Launches with New Capital to Support HealthTech and Longevity Startups

During the PFR Ventures conference, we announced the launch of Aegis Capital — a new investment vehicle focused on early-stage startups in HealthTech and Longevity. Backed by the PFR Starter program, the fund is part of a broader effort to support Polish innovation at the earliest and most critical stages of growth.

With fresh capital and a clear focus, we’re actively looking to partner with founders building solutions in digital health, diagnostics, therapeutics, and technologies that extend and improve human life.

Our team combines years of experience investing at the intersection of technology and healthcare. We’re also backed by private investors from the medical, tech, and capital markets sectors — all bringing strategic insight to support the companies we fund. To date, the team has completed over 20 early-stage investments, the majority in health-related ventures.

At Aegis, we believe that the future of medicine will be shaped by globally scalable, founder-led innovation. Our goal is to go beyond capital and become a hands-on partner to startups tackling the most pressing challenges in healthcare.